JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$4.76B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.21B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$3.81B |
| 4 |
Apple
AAPL
|
+$3.39B |
| 5 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$3.1B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.48B |
| 2 |
S&P Global
SPGI
|
+$2.45B |
| 3 |
Coca-Cola
KO
|
+$1.73B |
| 4 |
Adobe
ADBE
|
+$1.59B |
| 5 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$1.3B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.97% |
| 2 | Technology | 21.69% |
| 3 | Healthcare | 9.58% |
| 4 | Consumer Discretionary | 9.07% |
| 5 | Financials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
MRDB
6801
DELISTED
MariaDB plc
MRDB
| $48 | ﹤0.01% |
107
+23
| +27% | +$6 |
2023 Q3
2 quarters
|
|
6802
Paramount Gold Nevada
PZG
$103M
| $47 | ﹤0.01% |
117
+27
| +30% | +$10 |
2023 Q3
2 quarters
|
|
6803
vTv Therapeutics
VTVT
$121M
| $47 | ﹤0.01% |
2
+1
| +100% | +$13 |
2023 Q3
2 quarters
|
|
6804
WidePoint Corp
WYY
$75.6M
| $47 | ﹤0.01% |
18
+4
| +29% | +$11 |
2023 Q3
2 quarters
|
|
6805
Context Therapeutics
CNTX
$28.5M
| $46 | ﹤0.01% |
33
+10
| +43% | +$11 |
2023 Q3
2 quarters
|
|
6806
Fathom Holdings
FTHM
$11.4M
| $46 | ﹤0.01% |
23
+10
| +77% | +$27 |
2023 Q3
2 quarters
|
|
6807
John Hancock Mortgage-Backed Securities ETF
JHMB
$192M
| $46 | ﹤0.01% |
+2,131
| New | +$46K |
2024 Q1
0 quarters
|
|
6808
Corvex Inc
MOVE
$368M
| $45 | ﹤0.01% |
1
-5
| -83% | -$335 |
2023 Q3
2 quarters
|
|
6809
Surrozen
SRZN
$345M
| $45 | ﹤0.01% |
3
| – | – |
2023 Q3
2 quarters
|
|
6810
Willamette Valley Vineyards
WVVI
$9.81M
| $45 | ﹤0.01% |
9
+3
| +50% | +$16 |
2023 Q3
2 quarters
|
|
6811
Air T
AIRT
$80.4M
| $44 | ﹤0.01% |
2
-80
| -98% | -$1.39K |
2023 Q3
2 quarters
|
|
6812
Avalo Therapeutics
AVTX
$804M
| $44 | ﹤0.01% |
2
| – | – |
2023 Q4
1 quarter
|
|
6813
PEDEVCO
PED
$170M
| $44 | ﹤0.01% |
3
| – | – |
2023 Q3
2 quarters
|
|
6814
Columbia Research Enhanced Value ETF
REVS
$346M
| $44 | ﹤0.01% |
+1,835
| New | +$41.1K |
2024 Q1
0 quarters
|
|
|
SGMA
6815
DELISTED
Sigmatron International
SGMA
| $44 | ﹤0.01% |
12
+4
| +50% | +$13 |
2023 Q3
2 quarters
|
|
|
FPAY
6816
DELISTED
FlexShopper
FPAY
| $43 | ﹤0.01% |
29
+10
| +53% | +$13 |
2023 Q3
2 quarters
|
|
|
NINE
6817
DELISTED
Nine Energy Service
NINE
| $43 | ﹤0.01% |
19
| – | – |
2018 Q1
24 quarters
|
|
6818
PharmaCyte Biotech
PMCB
$4.3M
| $43 | ﹤0.01% |
18
+6
| +50% | +$13 |
2023 Q3
2 quarters
|
|
|
ALPP
6819
DELISTED
Alpine 4 Holdings Inc
ALPP
| $43 | ﹤0.01% |
60
+18
| +43% | +$12 |
2023 Q3
2 quarters
|
|
|
ICD
6820
DELISTED
Independence Contract Drilling, Inc.
ICD
| $43 | ﹤0.01% |
23
+4
| +21% | +$8 |
2016 Q4
29 quarters
|
|
6821
Daxor
DXR
$62M
| $42 | ﹤0.01% |
5
+1
| +25% | +$9 |
2023 Q3
2 quarters
|
|
|
TBLT
6822
DELISTED
ToughBuilt Industries, Inc. Common Stock
TBLT
| $42 | ﹤0.01% |
13
-18
| -58% | -$93 |
2023 Q2
3 quarters
|
|
6823
Moleculin Biotech
MBRX
$9.92M
| – | – |
0
| – | – |
2023 Q3
2 quarters
|
|
|
EDVA
6824
Endovia Health Sciences, Inc.
EDVA
$1.1M
| $41 | ﹤0.01% |
+1
| New | +$80 |
2023 Q3
2 quarters
|
|
|
SVT
6825
DELISTED
Servotronics
SVT
| $41 | ﹤0.01% |
3
+1
| +50% | +$13 |
2023 Q3
2 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2024 Portfolio in Review
As of Q1 2024, JP Morgan Chase held 8,132 positions worth $1.18T, up 14% from $1.04T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
JP Morgan Chase deployed $48.7B of net new capital in Q1 2024, opening 625 new positions and adding to 3,255 existing holdings. Its largest new stake was Flutter Entertainment: 1,314,201 shares worth $260M.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Vanguard Total International Bond ETF, an estimated $2.48B trimmed.
- JP Morgan Chase's largest Q1 2024 buy was Flutter Entertainment: 1,314,201 shares worth $260M.
- JP Morgan Chase added most to Vanguard S&P 500 ETF in Q1 2024, an estimated $4.76B increase.
- JP Morgan Chase's biggest Q1 2024 reduction was Vanguard Total International Bond ETF, cutting an estimated $2.48B.
- JP Morgan Chase fully exited BlackRock Flexible Income ETF in Q1 2024, selling an estimated $139M.
- JP Morgan Chase's ten largest holdings make up 21% of its $1.18T portfolio in Q1 2024.
- JP Morgan Chase opened 625 new positions and closed 764 in Q1 2024.
- JP Morgan Chase's portfolio value rose 14% quarter-over-quarter to $1.18T.
Based on JP Morgan Chase's 13F filing for Q1 2024, filed 10 May 2024.